EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Does pre-treatment with doxycycline improve the efficacy of combination minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium infections?

Kay Htaik iD, Lenka A Vodstrcil iD, Erica L Plummer iD, Laura G Matthews, Ivette Aguirre, Fabian Y S Kong iD, Catriona S Bradshaw iD

Antimicrobial Agents and Chemotherapy · 29.10.2026

DOI: 10.1128/aac.00560-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 29.10.2026. Verfasst von Kay Htaik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Royal Australasian College of Physicians, Department of Education, Australian Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial options for Mycoplasma genitalium are limited. Our prior study found a 14-day regimen of minocycline and metronidazole (minocycline + metronidazole) achieved microbial cure in 76.7% ( n = 56/73, 95% confidence interval [95% CI]: 65.4%–85.8%) of macrolide-resistant infections, with an efficacy of 90.3% ( n = 28/31, 95% CI: 74.2%–98.0%) if preceded by 7 days of doxycycline. We aimed to evaluate the efficacy and tolerability of sequential doxycycline and 14 days of minocycline + metronidazole in a larger cohort. Microbial cure was defined as a negative test-of-cure using transcription-mediated amplification 14–90 days after completing minocycline + metronidazole. The proportion cured and 95% CIs were calculated, and univariable and multivariable logistic regression analyses were performed to examine factors associated with cure. Adverse effect data were collated. Overall, microbial cure following minocycline + metronidazole was 80.9% ( n = 212/262, 95% CI: 75.6%–85.5%). Microbial cure was similar among 181 patients who received doxycycline pre-treatment (82.3%, 95% CI: 76.0%–87.6%) compared with 81 patients without pre-treatment (77.8%, 95% CI: 67.1%–86.3%, P = 0.387); individuals who had failed prior regimens were more likely to experience cure with doxycycline pre-treatment. A higher proportion of cervicovaginal infections were cured following minocycline + metronidazole compared to urethral infections. Gastrointestinal and central nervous system adverse effects were not significantly increased with the addition of doxycycline. In this larger data set, doxycycline pre-treatment did not significantly enhance the efficacy of minocycline + metronidazole. In our setting, cure following minocycline + metronidazole was comparable to cure following moxifloxacin, but this generic regimen is more widely accessible and cures 80% of M. genitalium infections with dual-class resistance. The regimen’s higher efficacy for cervicovaginal infections may reflect a sex-effect and/or its additional influence on vaginal dysbiosis.

Schlagwörter

Stichwörter der Autor:innen

Mycoplasma genitaliumdoxycyclinegeneric antimicrobialsmacrolide resistancemetronidazoleminocycline

Autor:innen und Institutionen

  • Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.
  • School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
  • Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Kay Htaik, Lenka A Vodstrcil, Erica L Plummer, Fabian Y S Kong, Catriona S Bradshaw

Förderung

  • National Health and Medical Research Council
  • Royal Australasian College of Physicians
  • Department of Education, Australian Government

Zitieren

APA

Htaik, K., Vodstrcil, L. A., Plummer, E. L., Matthews, L. G., Aguirre, I., Kong, F. Y. S., & Bradshaw, C. S. (2026). Does pre-treatment with doxycycline improve the efficacy of combination minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium infections?. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00560-26

Vancouver

Htaik K, Vodstrcil LA, Plummer EL, Matthews LG, Aguirre I, Kong FYS, et al. Does pre-treatment with doxycycline improve the efficacy of combination minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium infections?. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00560-26

BibTeX
@article{Htaik2026,
  author = {Htaik, Kay and Vodstrcil, Lenka A and Plummer, Erica L and Matthews, Laura G and Aguirre, Ivette and Kong, Fabian Y S and Bradshaw, Catriona S},
  title = {Does pre-treatment with doxycycline improve the efficacy of combination minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium infections?},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.00560-26}
}
Kostenlos starten →